ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO505

Dicer Promotes Renal Recovery and Limits Interstitial Fibrosis Following Kidney Injury

Session Information

  • CKD: Mechanisms - I
    November 07, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Lin, Jamie, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Lovisa, Sara, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Zeisberg, Michael, Univ Med Center of Goettingen, Goettingen, Germany
  • Sugimoto, Hikaru, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Xiao, Fei, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Calin, George, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Lebleu, Valerie, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Kalluri, Raghu, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Background

Renal tubulointerstitial fibrosis is the histopathological hallmark observed in chronic kidney disease; and activated fibroblasts, myofibroblasts, are the dominant extracellular matrix-producing cells that contribute to fibrosis development. Dysregulation or deletion of Dicer, a ribonuclease involved in microRNA (miRNA) generation, impacts kidney health and function. Since fibroblasts are key cells responsible for renal fibrosis, we investigated whether Dicer might effect myofibroblast and fibrosis formation by deletion of Dicer from myofibroblasts in vivo.

Methods

Dicerfl/fl mice were crossed with α-smooth muscle actin promoter (αSMACre) mice, a marker of activated fibroblast, to generate WT (αSMACre–;Dicerfl/fl) and Dicer conditional knock-out mice (αSMACre+;Dicerfl/fl, hereafter DicercKO). Mice were challenged to three different kidney injury models. MiRNAs from primary kidney fibroblasts were analyzed.

Results

Isolated human and mouse fibroblast from fibrotic kidneys demonstrated increased Dicer hypermethylation. DicercKO mice had no overt renal abnormalities. To determine whether deletion of Dicer in myofibroblast might impact the development of tubulointerstitial fibrosis, both WT and DicercKO mice underwent unilateral ureteral obstruction, nephrotoxic serum nephritis, and folic acid kidney injury. DicercKO mice displayed increased collagen deposition and tubulointerstitial fibrosis compared to WT animals in all three models. Furthermore, loss of Dicer resulted in an increase of proliferating, Ki67 positive, αSMA+ myofibroblasts. MiRNA array analysis of primary mouse fibroblasts from the UUO kidneys of DicercKO and WT mice revealed a differential expression of several miRNAs, including upregulation of miR-451, a Dicer-independent miRNA, in the DicercKO mice.

Conclusion

Renal tubulointerstitial fibrosis is the pathological sequelae observed in chronic injury. Dicer is critically involved in kidney homeostasis, and here we show that Dicer deletion in myofibroblasts resulted in differential miRNA expression and pathologic myofibroblast proliferation perpetuating fibrogenesis. Depletion of Dicer and associated miRNAs is pathogenic in various kidney injury models and accelerates kidney failure.